Filtered By:
Specialty: Neurology
Drug: Cilostazol
This page shows you your search results in order of date.
Order by Relevance | Date
Total 92 results found since Jan 2013.
Clinical Updates on Antiplatelet Therapy for Secondary Prevention in Acute Ischemic Stroke
Acta Neurol Taiwan. 2023 Sep 30;32(3):138-144.ABSTRACTAntiplatelet therapy is the first-line management for noncardioembolic transient ischemic attack (TIA) and acute ischemic stroke (IS). Herein, we review the safety and efficacy of antiplatelet therapies in patients with IS and TIA, primarily focusing on the acute stage. We discuss current antiplatelet monotherapy and the factors influencing efficacy and continuation rate according to clinical trial data. Aspirin remains the most commonly used first-line antiplatelet agent for preventing noncardioembolic stroke recurrence, and clopidogrel, cilostazol, and ticagrelor are ...
Source: Acta Neurologica Taiwanica - September 7, 2023 Category: Neurology Authors: Tsung-Lin Lee Yu-Ming Chang Pi-Shan Sung Source Type: research
Vessel Wall Changes on Serial High-Resolution MRI and the Use of Cilostazol in Patients With Adult-Onset Moyamoya Disease
CONCLUSIONS: Adult-onset MMD induces progressive shrinkage of large intracranial arteries, which cilostazol treatment may prevent. Further randomized clinical trials are warranted.TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02074111.PMID:36367058 | DOI:10.3988/jcn.2022.18.6.610
Source: Journal of Clinical Neurology - November 11, 2022 Category: Neurology Authors: Jae Youn Kim Hyung Jun Kim Eun-Hyeok Choi Kwang Hyun Pan Jong-Won Chung Woo-Keun Seo Gyeong-Moon Kim Tae Keun Jee Je Young Yeon Jong-Soo Kim Seung-Chyul Hong Min-Jung Seong Jihoon Cha Keon Ha Kim Pyoung Jeon Oh Young Bang Source Type: research
